Christopher P. Karch

910 total citations
18 papers, 501 citations indexed

About

Christopher P. Karch is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Christopher P. Karch has authored 18 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Virology. Recurrent topics in Christopher P. Karch's work include Immunotherapy and Immune Responses (7 papers), HIV Research and Treatment (5 papers) and Bacteriophages and microbial interactions (5 papers). Christopher P. Karch is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), HIV Research and Treatment (5 papers) and Bacteriophages and microbial interactions (5 papers). Christopher P. Karch collaborates with scholars based in United States, Egypt and Burkina Faso. Christopher P. Karch's co-authors include Peter Burkhard, Sara M. Paulillo, David E. Lanar, Gary R. Matyas, Zeinab H. Helal, Zoltán Beck, Mazhar I. Khan, Arthur Beauregard, Qing Fan and Eric A. Smith and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Christopher P. Karch

18 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher P. Karch United States 11 271 184 131 111 88 18 501
Christoph M. Janitzek Denmark 9 310 1.1× 167 0.9× 85 0.6× 135 1.2× 84 1.0× 14 540
Luciana D’Apice Italy 14 235 0.9× 233 1.3× 137 1.0× 145 1.3× 70 0.8× 29 582
Kimia Kardani Iran 12 433 1.6× 165 0.9× 142 1.1× 59 0.5× 104 1.2× 19 664
Darren B. Leneghan United Kingdom 7 309 1.1× 120 0.7× 91 0.7× 155 1.4× 84 1.0× 10 529
Anne‐Marie Andersson Denmark 11 261 1.0× 112 0.6× 106 0.8× 107 1.0× 92 1.0× 19 448
Tim D. Jones United Kingdom 14 389 1.4× 162 0.9× 150 1.1× 176 1.6× 76 0.9× 15 783
Iona J. Brian United Kingdom 5 236 0.9× 110 0.6× 74 0.6× 111 1.0× 70 0.8× 6 442
Sergei I. Bazhan Russia 15 288 1.1× 183 1.0× 110 0.8× 58 0.5× 98 1.1× 45 487
Stephen A. Kaba United States 11 384 1.4× 190 1.0× 70 0.5× 79 0.7× 43 0.5× 15 564
A. A. Ilyichev Russia 16 378 1.4× 203 1.1× 215 1.6× 160 1.4× 153 1.7× 74 669

Countries citing papers authored by Christopher P. Karch

Since Specialization
Citations

This map shows the geographic impact of Christopher P. Karch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Karch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Karch more than expected).

Fields of papers citing papers by Christopher P. Karch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Karch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Karch. The network helps show where Christopher P. Karch may publish in the future.

Co-authorship network of co-authors of Christopher P. Karch

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Karch. A scholar is included among the top collaborators of Christopher P. Karch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Karch. Christopher P. Karch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Karch, Christopher P. & Gary R. Matyas. (2021). The current and future role of nanovaccines in HIV-1 vaccine development. Expert Review of Vaccines. 20(8). 935–944. 7 indexed citations
2.
Miura, Kazutoyo, Christopher P. Karch, Zoltán Beck, et al.. (2021). Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity. Vaccines. 9(2). 103–103. 10 indexed citations
3.
Karch, Christopher P., Dominic Paquin‐Proulx, Michael A. Eller, et al.. (2020). Impact of the expression system on the immune responses to self-assembling protein nanoparticles (SAPNs) displaying HIV-1 V1V2 loop. Nanomedicine Nanotechnology Biology and Medicine. 29. 102255–102255. 4 indexed citations
4.
Bissati, Kamal El, Ying Zhou, Sara M. Paulillo, et al.. (2020). Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice. Scientific Reports. 10(1). 16984–16984. 16 indexed citations
5.
Munusamy, Shankar, et al.. (2020). Low‐Dose Metformin Treatment Ameliorates Renal Dysfunction and Fibrosis in a Mouse Model of Diabetic Nephropathy. The FASEB Journal. 34(S1). 1–1. 2 indexed citations
6.
Karch, Christopher P., Peter Burkhard, Gary R. Matyas, & Zoltán Beck. (2019). Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation. Journal of Visualized Experiments. 2 indexed citations
7.
Karch, Christopher P., Hongjun Bai, Oscar B. Torres, et al.. (2018). Design and characterization of a self-assembling protein nanoparticle displaying HIV-1 Env V1V2 loop in a native-like trimeric conformation as vaccine antigen. Nanomedicine Nanotechnology Biology and Medicine. 16. 206–216. 22 indexed citations
8.
Li, Jianping, Zeinab H. Helal, Christopher P. Karch, et al.. (2018). A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus. PLoS ONE. 13(9). e0203771–e0203771. 27 indexed citations
9.
Li, Jianping, Zeinab H. Helal, Brian S. Ladman, et al.. (2018). Nanoparticle Vaccine for Avian Influenza Virus: A Challenge Study against Highly Pathogenic H5N2 Subtype. 7(1). 8 indexed citations
10.
Karch, Christopher P., Gary R. Matyas, Peter Burkhard, & Zoltán Beck. (2018). Self-Assembling Protein Nanoparticles: Implications for HIV-1 Vaccine Development. Nanomedicine. 13(17). 2121–2125. 10 indexed citations
11.
Bissati, Kamal El, Ying Zhou, Sara M. Paulillo, et al.. (2017). Protein nanovaccine confers robust immunity against Toxoplasma. npj Vaccines. 2(1). 24–24. 43 indexed citations
12.
Herrera, Alberto, et al.. (2017). Mechanism Governing Human Kappa-Opioid Receptor Expression under Desferrioxamine-Induced Hypoxic Mimic Condition in Neuronal NMB Cells. International Journal of Molecular Sciences. 18(1). 211–211. 3 indexed citations
13.
14.
Karch, Christopher P., Tais A. P. F. Doll, Sara M. Paulillo, et al.. (2017). The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria. Journal of Nanobiotechnology. 15(1). 62–62. 31 indexed citations
15.
Karch, Christopher P., Sara M. Paulillo, Sharareh Emadi, et al.. (2016). Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge. Nanomedicine Nanotechnology Biology and Medicine. 13(1). 241–251. 51 indexed citations
16.
Karch, Christopher P. & Peter Burkhard. (2016). Vaccine technologies: From whole organisms to rationally designed protein assemblies. Biochemical Pharmacology. 120. 1–14. 179 indexed citations
17.
Beauregard, Arthur, Eric A. Smith, Brianna L. Petrone, et al.. (2013). Identification and characterization of small RNAs inYersinia pestis. RNA Biology. 10(3). 397–405. 36 indexed citations
18.
Karch, Christopher P., et al.. (2010). Effects of desferoxamine-induced hypoxia on neuronal human mu-opioid receptor gene expression. Biochemical and Biophysical Research Communications. 398(1). 56–61. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoph M. Janitzek Breakdown of academic impact, for papers by Luciana D’Apice Breakdown of academic impact, for papers by Kimia Kardani Breakdown of academic impact, for papers by Darren B. Leneghan Breakdown of academic impact, for papers by Anne‐Marie Andersson Breakdown of academic impact, for papers by Tim D. Jones Breakdown of academic impact, for papers by Iona J. Brian Breakdown of academic impact, for papers by Sergei I. Bazhan Breakdown of academic impact, for papers by Stephen A. Kaba Breakdown of academic impact, for papers by A. A. Ilyichev
Rankless by CCL
2026